BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33722502)

  • 21. lncRNA ST8SIA6-AS1 facilitates proliferation and invasion in liver cancer by regulating miR-142-3p.
    Zhang Y; Yang Y; Zhang Y; Liu Z
    Exp Ther Med; 2021 Dec; 22(6):1348. PubMed ID: 34659494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
    Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diagnostic Value of Serum ST8SIA6-AS1 as Biomarker in Hepatocellular Carcinoma.
    Qin SJ; Zhou HZ; Xu NS; Yang HC; Chen PX
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis.
    Mu B; Lv C; Liu Q; Yang H
    J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C; Li K; Huang R; Zhu J; Yang J
    Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
    Huang CM; Cao GY; Yang CX; Chen Y; Liu GD; Xu BW; Zhang X
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4203-4211. PubMed ID: 32373956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
    Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
    Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis.
    Fei Q; Song F; Jiang X; Hong H; Xu X; Jin Z; Zhu X; Dai B; Yang J; Sui C; Xu M
    Cancer Cell Int; 2020; 20():232. PubMed ID: 32536820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis.
    Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
    Peng Z; Ouyang X; Wang Y; Fan Q
    BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.
    Zhu H; Zhang H; Pei Y; Liao Z; Liu F; Su C; Liu Y; Dong R; Song J; Zhang X; Fan Y; Liang H; Zhang B; Chen X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):57. PubMed ID: 33541391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
    Zhang L; Zhao Y; Guan H; Zhang D
    Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
    Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
    J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.